Skip to content
Operation Infinite Justice – Lifestyle
Author:
BillionToOne/Biocom
Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions
August 18, 2026
BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar
July 20, 2026
BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026
July 15, 2026
BillionToOne’s Northstar Response® Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-of-Care Imaging for Cancer Patients in Peer-Reviewed Study
June 29, 2026
BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference
May 27, 2026
BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance
May 6, 2026
BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics
May 3, 2026
BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026
April 15, 2026
BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology
April 2, 2026